Xuanhao Chan To Speak On Panel at Interchange
Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.
Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.
Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.
Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.
Being the main technical officer for FIP, he leads ongoing analysis of current affairs in pharmaceutical policies and global trends so as to prepare internal and external policy papers and to represent the Federation at key events such as the World Health Assembly. He also represents FIP in providing expert opinion on pharmacy and pharmaceutical policy issues in the WHO Expert Committee on specifications of pharmaceuticals.
In the area of combating counterfeit medicines, he has led communications activities for the International Medical Products Anti-Counterfeiting Task-force (IMPACT), since 2006, on behalf of FIP and the World Health Professions Alliance. In 2010, he worked closely with the WHO Secretariat to organize the first WHO Open Forum on IMPACT and counterfeit medical products for Member States.
Since 2009, he has also been managing the World Health Professions Alliance global campaign on combating counterfeit medicines. A key objective of this campaign is to build capacity for health professionals and their national associations to play a stronger role in combating counterfeit medicines from a public health perspective. WHPA also aims to facilitate more dialogue among key stakeholders and health professional leaders with a strong focus on ensuring quality, safety and better use of medicines.
FIP is the global federation of national associations of pharmacists and pharmaceutical scientists and is in official relations with the World Health Organization (WHO). Through its 124 Member Organisations FIP represents and serves more than two million practitioners and scientists around the world.
The World Health Professions Alliance WHPA brings together the global organizations representing the world’s dentists, nurses, pharmacists, physical therapists and physicians and speaks for more than 26 million health care professionals in more than 130 countries. WHPA works to improve global health and the quality of patient care and facilitates collaboration among the health professions and major stakeholders.
Hear what stake holders and thought leaders have to say about medicine counterfeiting at the 2011 Interchange on October 27 at the National Press Club.
